Phlebotomy in Cluster Headache management involves therapeutic bloodletting to reduce blood viscosity and potentially modulate inflammatory responses. By removing a specific volume of blood, the procedure may alter hematological parameters, potentially decreasing vascular resistance and neurogenic inflammation associated with cluster headache pathophysiology. The primary mechanism is thought to involve reducing blood thickness and inflammatory mediators, which can potentially interrupt the neurological cascade contributing to cluster headache episodes.